" class="no-js "lang="en-US"> Crown Bioscience - Medtech Alert
Friday, March 29, 2024
Crown Bioscience | PTF

Crown Bioscience

About Crown Bioscience

Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global CRO that provides preclinical and translational platforms to help our customers advance their research and development in oncology, immuno-oncology, and immune-mediated inflammatory diseases. We are the exclusive preclinical CRO to offer tumor organoid services with the well-established Hubrecht Organoid Technology. In addition, we have developed the largest commercially available PDX collection in the world. We focus on helping our customers develop novel therapies to maximize the chances that patients receive the right treatment at the right time. Founded in 2006, Crown Bioscience has 13 facilities across the United States, Europe, and Asia.

Related Story

Crown Bioscience to Acquire Indivumed Service Business and Supporting Biobank

January 25 2023

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has […]